CSI Market
Sign In | Register

Protagenic Therapeutics Inc new (PTIX) Annual Balance Sheets

Annual · GAAP · USD millions
Access PTIX quarterly Balance Sheets →
This balance sheet overview for Protagenic Therapeutics Inc new spans from Dec 31 2021 to Mar 31 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1.51
Marketable Securities, Current SH0.00
Cash & Short-term Investments1.00
Other Current Assets0.00
Prepaid Expense, Current AS0.03
Total Current Assets1.54
Equipment/Property/Plant Net0.16
Intangible Assets2.09
Tax Assets, Noncurrent8.35
Other Assets, Noncurrent0.00
Total Assets3.65
Liabilities
Accounts Payable, Current AC0.95
Accrued Liabilities, Current AC0.08
Short-term Debt0.00
Other Liabilities, Current0.00
Total Current Liabilities1.03
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Accounts Payable And Accrued Liabilities Related Party Current-
Total Liabilities1.03
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock6.99
Retained Earnings / Accumulated Deficit-4.03
Accumulated Other Comprehensive Income-0.34
Other Equity0.00
Common Stockholder's Equity2.62
Total Stockholder's Equity2.62
Liabilities & Stockholder's Equity3.65
4 historic quarters locked

Sign in to unlock the full Protagenic Therapeutics Inc new balance sheet history.

Sign In Create Free Account

About Protagenic Therapeutics Inc New Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20260331)
  • Filed with the SEC: August 14, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-038255

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.